Biological therapies, advanced therapies, regenerative medicine, minimally invasive treatments, platelet-rich plasma, traumatology and orthopaedics, plasma rich in growth factors, paediatric orthopaedics, R+D+i, pain unit.
The Advanced Biological Therapy Unit (UTBA), directed by Dr. Mikel Sánchez, is active in research, clinical trials and outreach to provide effective solutions to patients’ problems and to contribute to the advancement of regenerative medicine in the field of musculoskeletal injuries. Its focus is on biological techniques and minimally invasive approaches to treat injuries in joints, bones, tendons, muscles and other tissues.
Thus, UTBA’s main objective is to transfer the most innovative biomechanical and biological knowledge from research to the clinical setting, developing treatments and solutions for musculoskeletal problems. Platelet-rich plasma therapies (PRPs) are an important part of this translational research work.
DESCRIPTION
The Advanced Biological Therapy Unit (UTBA), directed by Dr. Mikel Sánchez, is active in research, clinical trials and outreach to provide effective solutions to patients’ problems and to contribute to the advancement of regenerative medicine in the field of musculoskeletal injuries. Its focus is on biological techniques and minimally invasive approaches to treat injuries in joints, bones, tendons, muscles and other tissues.
Thus, UTBA’s main objective is to transfer the most innovative biomechanical and biological knowledge from research to the clinical setting, developing treatments and solutions for musculoskeletal problems. Platelet-rich plasma therapies (PRPs) are an important part of this translational research work.
Keywords
Biological therapies, advanced therapies, regenerative medicine, minimally invasive treatments, platelet-rich plasma, traumatology and orthopaedics, plasma rich in growth factors, paediatric orthopaedics, R+D+i, pain unit.
